Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2011
06/22/2011EP2336313A1 Methods for production of proteins
06/22/2011EP2336312A1 Triterpene oxidase derived from glychyrrhiza plant, gene encoding the oxidase, and method for utilizing the gene
06/22/2011EP2336311A1 Anti-tuna vasa antibody
06/22/2011EP2336309A2 Polypeptides having endoglucanase activity and polynucleotides encoding same
06/22/2011EP2336303A1 NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM
06/22/2011EP2336302A1 Nucleotide sequence encoding the enzyme I-sceI and the uses thereof
06/22/2011EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom
06/22/2011EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom
06/22/2011EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom
06/22/2011EP2336298A2 Postpartum cells derived from placental tissue and methods of making and using the same
06/22/2011EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
06/22/2011EP2336190A2 Anti-VEGF antibodies
06/22/2011EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
06/22/2011EP2336186A1 Humanized antibodies against ICAM-1, their production and uses
06/22/2011EP2336185A1 Anti- alpha v beta 6 antibodies
06/22/2011EP2336176A1 Antibodies directed against hepatitis c virus e1e2 complex, and their epitopes
06/22/2011EP2336175A1 Monoclonal antibodies to human immunodeficiency virus and uses thereof
06/22/2011EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
06/22/2011EP2336168A1 Novel protein and method for producing the protein
06/22/2011EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy
06/22/2011EP2335728A1 Specific binding proteins and uses thereof
06/22/2011EP2335726A1 Fusion molecules and methods for treatment of immune diseases
06/22/2011EP2335720A1 Autologous T-cell vaccines materials and methods
06/22/2011EP2335712A2 Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of panax ginseng including mountain ginseng or ginseng as active ingredient
06/22/2011EP2335650A1 Particulate cartilage system
06/22/2011EP2334804A2 Co-culture compositions and methods
06/22/2011EP2334798A2 Glutamate decarboxylase (gad) transgenic plants that exhibit altered plant architecture
06/22/2011EP2334787A1 Method of correlating marker molecule concentration to a specific cell potency level in chondrocyte culture
06/22/2011EP2334786A2 Isolation and identification of glycosaminoglycans
06/22/2011EP2334785A2 Compositions containing platelet contents
06/22/2011EP2334784A1 Use of hsa-producing cells
06/22/2011EP2334783A2 Adherent cells from placenta tissue and use thereof in therapy
06/22/2011EP2334696A1 G6pc2-encoded beta cell surface tags
06/22/2011EP1999257B1 Polypeptides having endoglucanase activity and polynucleotides encoding same
06/22/2011EP1987137B1 Synthesis of sialic acid in plants
06/22/2011EP1874921B1 Transplantation of differentiated immature adipocytes and biodegradable scaffold for tissue augmentation
06/22/2011EP1836226B1 Antibodies against il-13 receptor alpha 1 and uses thereof
06/22/2011EP1680503B1 Recombinant production of antimicrobial agents
06/22/2011EP1546388B1 Real time measurement of cellular responses
06/22/2011EP1546174B1 Methods and compositions for rna interference
06/22/2011EP1419240B1 Production and use of human cd124 and cd116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents
06/22/2011EP1328545B1 Human gene critical to fertility
06/22/2011EP1290161B1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi
06/22/2011EP1207876B1 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing
06/22/2011EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
06/22/2011CN1891714B Ligand for herpes simplex virus entry mediator and methods of use
06/22/2011CN1447819B Human CYR 61
06/22/2011CN1405300B Cell with modified cell membrane
06/22/2011CN1384885B Preparation method of recombinant adenoviruses and adenovirus banks
06/22/2011CN102105789A Brown adipocyte progenitors in human skeletal muscle
06/22/2011CN102105580A Treatment of pluripotent cells
06/22/2011CN102105579A Isolation, characterization and propagation of germline stem cells
06/22/2011CN102103141A Immunity-chromatography kit for rapid diagnosis of malaria and its pathogen species and preparation method thereof
06/22/2011CN102102111A Method for synthesizing optically-active aryl vicinal diol under catalysis of plant cells
06/22/2011CN102102106A Methods for modifying plant characteristics
06/22/2011CN102102103A Experiment method for establishing an animal model for studying oral white sponge nevus of the Chinese
06/22/2011CN102102094A Thermostable lipase, expression of coding gene of thermostable lipase and applications of thermostable lipase
06/22/2011CN102102093A High temperature lipase, preparation for mutants thereof and application thereof
06/22/2011CN102102091A C genotype entecavir-resistant mutation HBV stable replication and expression cell line
06/22/2011CN102102090A Method for inducing in vitro directed differentiation of stem cells through non-contact coculture
06/22/2011CN102102089A Method for establishing magnolia officinalis suspension culture system
06/22/2011CN102101882A Plant low temperature stress resistance-related protein and encoding gene and application thereof
06/22/2011CN102100925A Preparation method of novel injectable polypeptide hydrogel
06/22/2011CN102100910A Method for producing viral vaccines
06/22/2011CN101514340B Sequence and application of a promoter of a human autophagic gene beclin 1
06/22/2011CN101485342B Animal antifeedant prepared from protonema of Tortula muralis Hedw. cultivated with cell engineering
06/22/2011CN101455179B Tissue culture method of aged Sinojackia xylocarpa
06/22/2011CN101300343B Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same
06/22/2011CN101148671B Spartina anglica sodium hydrogen pump protein gene SaNHX and application thereof
06/21/2011US7964779 Celery cultivar ADS-18
06/21/2011US7964777 Soybean cultivar 7629164
06/21/2011US7964776 Soybean cultivar 72143110
06/21/2011US7964775 Soybean cultivar 76171112
06/21/2011US7964773 Of given amino acid sequence; transforming plants to be resistant to insects and larvae
06/21/2011US7964772 Pea line 08270930
06/21/2011US7964769 Using vector transfromation to generate transgenic soybean seeds with enhanced concentrations of lipids, fatty acids, starches and storage proteins
06/21/2011US7964768 Non-dehiscent sesame variety Sesaco 27
06/21/2011US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics
06/21/2011US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains
06/21/2011US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease
06/21/2011US7964578 Conjugates and compositions for cellular delivery
06/21/2011US7964570 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3
06/21/2011US7964555 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions
06/21/2011US7964406 Means and methods for producing a stabilized cell of interest
06/21/2011US7964405 Plant cultivation method
06/21/2011US7964404 Methods for increasing germination vigor by early singulation of conifer somatic embryos
06/21/2011US7964402 Methods for culture and production of single cell populations of human embryonic stem cells
06/21/2011US7964401 Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3
06/21/2011US7964400 Immune potentiating compositions of cancer cells
06/21/2011US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth
06/21/2011US7964398 Modified vaccinia ankara virus variant and cultivation method
06/21/2011US7964397 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
06/21/2011US7964396 Modified vaccinia ankara virus variant and cultivation method
06/21/2011US7964395 Modified vaccinia ankara virus variant and cultivation method
06/21/2011US7964394 Spore-like cells and uses thereof
06/21/2011US7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
06/21/2011US7964346 Using avian cells as screening tools in monitoring and/or identifying viricidal agents
06/21/2011US7963906 Imaging and evaluating embryos, oocytes, and stem cells
06/21/2011CA2439857C Caloporoside derivatives, process for their preparation and their use
06/21/2011CA2413316C Genetically modified plants with heterogeneous proteinase inhibitor sapin2a and methods of use thereof for the inhibition of endogenous trypsin-and chymotrypsin-like activities